Skip to content

CLEM - NURSING: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CLEM - NURSING

BE 1012.800.259
NACE 86.940, Nursing and midwifery
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€26,789
2024 · €34,162-€7,373
Equity
€61,051
2024 · €34,262+€26,789
Cash
€50,170
2024 · €9,049+€41,121
Balance sheet total
€78,604
2024 · €43,093+€35,511

Largest movements

2024 to 2025
Assets
  • Cash +€41,121

    up €41,121 (+454.4%), from €9,049 to €50,170

    mainly Net result for the year (+€26,789) and Tax, wage and social debts (+€8,171)

  • Tangible fixed assets -€5,160

    down €5,160 (-25.3%), from €20,400 to €15,240

  • Receivables within one year -€941

    down €941 (-6.9%), from €13,644 to €12,703

    of which Trade receivables: -€1,482

Equity and liabilities
  • Profit (loss) carried forward +€26,789

    up €26,789 (+78.4%), from €34,162 to €60,951

  • Tax, wage and social debts +€8,171

    up €8,171 (+92.5%), from €8,831 to €17,002

Income statement
  • Depreciation +€4,060

    up €4,060 (+369.1%), from €1,100 to €5,160

  • Gross operating margin -€3,936

    down €3,936 (-8.9%), from €44,093 to €40,157

  • Taxes -€660

    down €660 (-7.5%), from €8,831 to €8,171

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €34,162
Gross operating margin -€3,936
Depreciation -€4,060
Financial charges -€37
Taxes +€660
Result 2025 €26,789

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€41,121
Investment €0
Financing €0
Cash 2024 €9,049
Net result for the year +€26,789
Depreciation +€5,160
Receivables within one year +€941
Deferred charges and accrued income -€491
Trade debts +€551
Tax, wage and social debts +€8,171
Cash 2025 €50,170
Every line side by side 29 lines
Line Code 2024 2025 Change %
Total assets 20/58 €43,093 €78,604 +€35,511 +82.4%
Fixed assets 21/28 €20,400 €15,240 -€5,160 -25.3%
Tangible fixed assets 22/27 €20,400 €15,240 -€5,160 -25.3%
Furniture and vehicles 24 €20,400 €15,240 -€5,160 -25.3%
Current assets 29/58 €22,693 €63,364 +€40,671 +179.2%
Amounts receivable within one year 40/41 €13,644 €12,703 -€941 -6.9%
Trade receivables 40 €7,669 €6,187 -€1,482 -19.3%
Other amounts receivable 41 €5,975 €6,516 +€541 +9.1%
Cash at bank and in hand 54/58 €9,049 €50,170 +€41,121 +454.4%
Deferred charges and accrued income 490/1 - €491 +€491
Total equity and liabilities 10/49 €43,093 €78,604 +€35,511 +82.4%
Equity 10/15 €34,262 €61,051 +€26,789 +78.2%
Contributions 10/11 €100 €100 = 0.0%
Profit (loss) carried forward 14 €34,162 €60,951 +€26,789 +78.4%
Amounts payable 17/49 €8,831 €17,553 +€8,722 +98.8%
Amounts payable within one year 42/48 €8,831 €17,553 +€8,722 +98.8%
Trade debts 44 - €551 +€551
Suppliers 440/4 - €551 +€551
Taxes, remuneration and social security 45 €8,831 €17,002 +€8,171 +92.5%
Taxes 450/3 €8,831 €17,002 +€8,171 +92.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,100 €5,160 +€4,060 +369.1%
Gross operating margin 9900 €44,093 €40,157 -€3,936 -8.9%
Operating profit (loss) 9901 €42,993 €34,997 -€7,996 -18.6%
Financial charges 65/66B - €37 +€37
Recurring financial charges 65 - €37 +€37
Profit (loss) for the period before taxes 9903 €42,993 €34,960 -€8,033 -18.7%
Income taxes 67/77 €8,831 €8,171 -€660 -7.5%
Profit (loss) for the period 9904 €34,162 €26,789 -€7,373 -21.6%
Profit (loss) for the period to be appropriated 9905 €34,162 €26,789 -€7,373 -21.6%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.